Replies to post #53848 on Tauriga Sciences Inc (fka TAUG)

[Johnny_C]

Nestle has been on the periphery of TAUG's products since the rollout of the gum. Matt had nothing to do with Nestle approving its biggest ice cream distributor from selling the product when it first launched.

I am not sure if he had anything to do with Nestle's pharma division sponsoring and funding most of the liver toxicity study. I doubt it as that would have been a decision from the pharma side.

CBD is very big in the US and EU. I think TAUG already has inroads with Walmart, CVS, Target, Amazon ect, they are just not selling CBD yet. I hope that other distribution channels are open through this.

Fun fact, a previous board member of TAUG who loved the products had to resign when he became a Board member of Draft Kings. They did not want any of their Directors on micro - cap boards.

I doubt the 29th largest company in the world would let an executive as high the chain up as Matt willy-nilly go on the Board of Advisors. Of course, there will be some jealous haters that have not invested a penny in TAUG and have been wrong about many things for years try to babble nonsense.

[Johnny_C]

Regardless of Nestle or retail sales, if there is going to be a monster payoff here the nausea trial for chemo patients will be it.

TAUG certainly has the ability to be a winner based on retail for sure, maybe even have a $100 million or more market cap from it. But the elephant is the pharma.

Nestle bought Skinny Cow when it was a micro cap and turned that into a very profitable brand